Melatonin (part5) on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients published in International Journal of Infectious Diseases 2021 (online) and 2022 (printed)

Authors' Conclusions: Adjuvant use of melatonin may help to reduce thrombosis, sepsis, and mortality in COVID-19 patients

Dr Alex Kennerly Vasquez

Feb 27, 2022

∙ Paid

1. The safety and effectiveness of this intervention helps us understand the recent attacks against melatonin by CNN and the A.M.A.

2. The dose of 10 mg is reasonable if not minimal for an acute illness. Note that this is the same dose used in infants with sepsis as I have discussed in my published antiviral protocol; obviously, dose-optimization studies need to be completed to determine the optimal dose for adults which is quite likely in the range of 40-500 mg rather than 3-10 mg.

Title: The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients

Journal: International Journal of Infectious Diseases 2021 (online) and 2022 (printed)

Methods: single-center, prospective, randomized clinical trial conducted from 1 December 2020 to 1 June 2021 in Iraq; patients were chosen by a blocked randomization design.

Patients: 158 patients with severe COVID-19: 82 in the melatonin group (who received 10 mg melatonin in addition to standard therapeutic care) and 76 in the control group (given standard therapeutic care only).

Criteria: thrombosis, sepsis, and mortality rate on days 5, 11, and 17

Results: “The intervention group consisted of 82 patients, while the control group consisted of 76 patients. In comparison to the control group, thrombosis and sepsis developed significantly less frequently (P < 0.05) in the melatonin group during the second week of infection, while mortality was significantly higher in the control group (P < 0.05).

Conclusions: Adjuvant use of melatonin may help to reduce thrombosis, sepsis, and mortality in COVID-19 patients.”

DrV’s Newsletter, Notes, Essays, Articles, Videos, and Book Chapters

CNN and A.M.A. fail at math, science, and logic when attacking MELATONIN (part4)

This story keeps getting better! Part 1: I had been thinking about melatonin with regard to patient care and some new research when I noticed a new smear campaign by the American Medical Association and CNN recently. Part 2: The American Medical Association post on social media was a combination of direct misinformation along with a hyperlink to the article published by CNN which of course glorified in a reciprocal manner a recent publication by the American Medical Association. CNN repeats what the AMA published in its journal JAMA, and AMA reciprocates by guiding traffic to the CNN website. Like one hand washing the other, in the same dirty water…

3 years ago · 3 likes · Dr Alex Kennerly Vasquez

Share DrV’s Newsletter, Notes, Essays, Articles, Videos, and Book Chapters

DrV’s Newsletter, Notes, Essays, Articles, Videos, and Book Chapters

Self-Paced Learning: Antiviral Nutrition Protocol Structure, Science, Application

We all need a better understanding of viral infections, especially now Whether we are doctors or patients, we all have an interest in viral infections because of their prevalence in the population and also their clinical consequences. However, my experience/observation is that most people don’t understand the basic “structure of a viral infection” and th…

4 years ago · 12 likes · Dr Alex Kennerly Vasquez

DrV’s Newsletter, Notes, Essays, Articles, Videos, and Book Chapters

Melatonin (part5) on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients published in International Journal of Infectious Diseases 2021 (online) and 2022 (printed)

Authors' Conclusions: Adjuvant use of melatonin may help to reduce thrombosis, sepsis, and mortality in COVID-19 patients

Commentary by DrV:

1. The safety and effectiveness of this intervention helps us understand the recent attacks against melatonin by CNN and the A.M.A.

Full-text PDF article included below

This post is for paid subscribers